Yilmaz, Oznur <br/><br/>
Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice.  [electronic resource] 

 -  Growth factors (Chur, Switzerland)  2015 
 - 366-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2292 
<br/><br/><label>Standard No.: </label>10.3109/08977194.2015.1109511  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Antibiotics, Antineoplastic--adverse effects<br/>Bleomycin--adverse effects<br/>Cell Proliferation--drug effects<br/>Collagen Type I--metabolism<br/>Dasatinib--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Lung--pathology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>PTEN Phosphohydrolase--biosynthesis<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pulmonary Fibrosis--chemically induced<br/>Receptor, Platelet-Derived Growth Factor alpha--metabolism<br/>Receptors, Platelet-Derived Growth Factor--antagonists & inhibitors<br/>src-Family Kinases--metabolism